Market Cap : 133.57 B | Enterprise Value : 163.38 B | PE Ratio : 21.16 | PB Ratio : 55.21 |
---|
NAS:AMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:AMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2022-08-19), Amgen's share price is $249.70. Amgen's Book Value per Share for the quarter that ended in Jun. 2022 was $4.52. Hence, Amgen's PB Ratio of today is 55.22.
The historical rank and industry rank for Amgen's PB Ratio or its related term are showing as below:
During the past 13 years, Amgen's highest PB Ratio was 148.84. The lowest was 2.02. And the median was 4.38.
AMGN's PB Ratio is ranked worse thanDuring the past 12 months, Amgen's average Book Value Per Share Growth Rate was -68.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -15.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -21.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -7.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Amgen was 69.30% per year. The lowest was -27.30% per year. And the median was 16.00% per year.
The historical data trend for Amgen's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Amgen's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Amgen's PB Ratio distribution charts can be found below:
* The bar in red indicates where Amgen's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Amgen's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Jun. 2022) |
= | 249.70 | / | 4.522 | |
= | 55.22 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Amgen's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Miller Derek | officer: SVP, Human Resources | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Khosla Rachna | officer: SVP, Business Development | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Ishrak Omar | director | 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
Louie Linda H. | officer: VP, Finance & CAO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Miles Amy E | director | |
Grygiel Nancy A. | officer: SVP & CCO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Griffith Peter H. | officer: EVP & CFO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Gordon Murdo | officer: EVP Global Commercial Ops | C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVE NEW YORK NY 10154 |
Reese David M | officer: EVP, Research and Development | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Druker Brian | director | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 |
Austin Wanda M | director | 6001 BOLLINGER CANYON ROAD SAN RAMON CA 94583 |
Holley Charles M | director | |
Johnston Lori A | officer: SVP, HR | C/O AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Kullman Ellen Jamison | director | UNITED TECHNOLOGIES CORP 10 FARM SPRINGS ROAD FARMINGTON CT 06032 |
Santos Esteban | officer: EVP, Operations | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
From GuruFocus
By PRNewswire 02-03-2022
By PRNewswire 03-02-2022
By PRNewswire 02-16-2022
Other Sources
By Zacks 2022-03-23
By tipranks.com 2022-03-22
By Zacks 2022-03-15
By Zacks 2022-04-05
By Zacks 2022-03-03
By Zacks 2022-03-21
By Zacks 2022-02-25
By Zacks 2022-03-08
By Fool 2022-03-16
By Zacks 2022-03-21
By Zacks 2022-03-07
By Zacks 2022-03-22
By Zacks 2022-03-11